Am J Manag Care. 2023;29(9):e261. https://doi.org/10.37765/ajmc.2023.89427
_____
We would like to share ideas on the article “COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States” published in the June 2023 issue of The American Journal of Managed Care.1 Mamudu et al investigated the link between health literacy (HL) and COVID-19 vaccine hesitancy in a population from 14 Southern states. They found that HL was not a significant predictor of vaccine hesitation in the study population, implying that the Southern region’s low immunization rates may not be related to lack of information about COVID-19. According to the study authors, this highlights the urgent need for place-based or contextual study on why vaccine hesitancy in the region transcends most socioeconomic inequalities.
According to the study’s findings, 23.5% of participants were hesitant to get vaccinations overall, and individuals with low/moderate HL were more likely to be hesitant to get vaccinations than people with high HL. However, there was no statistically significant link between HL and vaccine hesitation. The study also discovered that although race/ethnicity and vaccine hesitation were not statistically substantially correlated, personal opinion of COVID-19 threat was strongly associated with decreased likelihood of vaccine hesitancy. Although the study sheds some light on the potential link between HL and COVID-19 vaccine hesitancy, there are a number of study limitations that should be considered when interpreting the findings. The study’s self-reported assessments of HL and vaccine hesitation, which might not correctly reflect people’s real HL or vaccine behavior, are the first drawback. Second, the study’s target demographic, which was limited to 14 Southern states, may not be indicative of other regions, nations, or continents. Last but not least, the study failed to take into account additional possible factors that can affect vaccine hesitancy, such as political beliefs or inaccurate information regarding vaccines.
It is crucial to stress that initiatives that foster vaccine acceptance ought to be applauded. Every time a new COVID-19 vaccine is developed and made accessible to the general public, concerns are raised by the public about safety and efficacy. Individuals may become apprehensive if they receive bad news about adverse reactions to a vaccine. Several publications have explored the public’s expected negative reactions to COVID-19 immunization.2 The beginning of the COVID-19 pandemic, as well as the surrounding environment, had an impact on the pattern of resistance.3,4 Because of the irregular character of the hesitancy pattern throughout time, the effect of promoting vaccination at different times may vary. As a result, information about the COVID-19 pandemic must be included in the context of all studies about vaccine hesitancy. Even if the pandemic’s circumstances are altered, the vaccination’s acceptance percentage is unlikely to change.
If more research is needed, it should focus on identifying and addressing the main causes of vaccine hesitancy, such as false information, mistrust, and access barriers, as well as developing and evaluating effective vaccine hesitancy strategies in various populations and situations.
Author Affiliations: Private academic consultant (AK), Samraong, Cambodia; Chandigarh University (VW), Punjab, India; Joseph Ayo Babalola University (VW), Ikeji-Arakeji, Nigeria.
Source of Funding: None.
Author Disclosures: The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
Authorship Information: Concept and design (AK); acquisition of data (AK); analysis and interpretation of data (AK, VW); drafting of the manuscript (AK); critical revision of the manuscript for important intellectual content (AK, VW); statistical analysis (AK); provision of patients or study materials (AK); obtaining funding (AK); administrative, technical, or logistic support (AK); and supervision (VW).
Address Correspondence to: Amnuay Kleebayoon, PhD, 123 Main Rd, Samraong, Oddar Meanchey, 240203 Cambodia. Email: amnuaykleebai@gmail.com.
REFERENCES
1. Mamudu HM, Ahuja M, Adeniran E, et al. COVID-19 vaccine hesitancy and health literacy in US Southern states. Am J Manag Care. 2023;29(6):300-306. doi:10.37765/ajmc.2023.89371
2. Mungmunpuntipantip R, Wiwanitkit V. COVID-19 vaccination hesitancy. Recenti Prog Med. 2021;112(9):596. doi:10.1701/3658.36425
3. Xiao J, Cheung JK, Wu P, Ni MY, Cowling BJ, Liao Q. Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: serial cross-sectional surveys. Lancet Reg Health West Pac. 2022;23:100441. doi:10.1016/j.lanwpc.2022.100441
4. Marendic M, Aranza D, Aranza I, Vrdoljak D, Podrug M, Milic M. Determinants of COVID vaccination willingness among health and non-health studies students: a cross-sectional study. Vaccines (Basel). 2023;11(5):981. doi:10.3390/vaccines11050981
Comment on COVID-19 Vaccine Hesitancy and Health Literacy
Viroj Wiwanitkit, MD
This letter discusses COVID-19 vaccine hesitancy and health literacy.
Am J Manag Care. 2023;29(9):e261. https://doi.org/10.37765/ajmc.2023.89427
We would like to share ideas on the article “COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States” published in the June 2023 issue of The American Journal of Managed Care.1 Mamudu et al investigated the link between health literacy (HL) and COVID-19 vaccine hesitancy in a population from 14 Southern states. They found that HL was not a significant predictor of vaccine hesitation in the study population, implying that the Southern region’s low immunization rates may not be related to lack of information about COVID-19. According to the study authors, this highlights the urgent need for place-based or contextual study on why vaccine hesitancy in the region transcends most socioeconomic inequalities.
According to the study’s findings, 23.5% of participants were hesitant to get vaccinations overall, and individuals with low/moderate HL were more likely to be hesitant to get vaccinations than people with high HL. However, there was no statistically significant link between HL and vaccine hesitation. The study also discovered that although race/ethnicity and vaccine hesitation were not statistically substantially correlated, personal opinion of COVID-19 threat was strongly associated with decreased likelihood of vaccine hesitancy. Although the study sheds some light on the potential link between HL and COVID-19 vaccine hesitancy, there are a number of study limitations that should be considered when interpreting the findings. The study’s self-reported assessments of HL and vaccine hesitation, which might not correctly reflect people’s real HL or vaccine behavior, are the first drawback. Second, the study’s target demographic, which was limited to 14 Southern states, may not be indicative of other regions, nations, or continents. Last but not least, the study failed to take into account additional possible factors that can affect vaccine hesitancy, such as political beliefs or inaccurate information regarding vaccines.
It is crucial to stress that initiatives that foster vaccine acceptance ought to be applauded. Every time a new COVID-19 vaccine is developed and made accessible to the general public, concerns are raised by the public about safety and efficacy. Individuals may become apprehensive if they receive bad news about adverse reactions to a vaccine. Several publications have explored the public’s expected negative reactions to COVID-19 immunization.2 The beginning of the COVID-19 pandemic, as well as the surrounding environment, had an impact on the pattern of resistance.3,4 Because of the irregular character of the hesitancy pattern throughout time, the effect of promoting vaccination at different times may vary. As a result, information about the COVID-19 pandemic must be included in the context of all studies about vaccine hesitancy. Even if the pandemic’s circumstances are altered, the vaccination’s acceptance percentage is unlikely to change.
If more research is needed, it should focus on identifying and addressing the main causes of vaccine hesitancy, such as false information, mistrust, and access barriers, as well as developing and evaluating effective vaccine hesitancy strategies in various populations and situations.
Author Affiliations: Private academic consultant (AK), Samraong, Cambodia; Chandigarh University (VW), Punjab, India; Joseph Ayo Babalola University (VW), Ikeji-Arakeji, Nigeria.
Source of Funding: None.
Author Disclosures: The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
Authorship Information: Concept and design (AK); acquisition of data (AK); analysis and interpretation of data (AK, VW); drafting of the manuscript (AK); critical revision of the manuscript for important intellectual content (AK, VW); statistical analysis (AK); provision of patients or study materials (AK); obtaining funding (AK); administrative, technical, or logistic support (AK); and supervision (VW).
Address Correspondence to: Amnuay Kleebayoon, PhD, 123 Main Rd, Samraong, Oddar Meanchey, 240203 Cambodia. Email: amnuaykleebai@gmail.com.
REFERENCES
1. Mamudu HM, Ahuja M, Adeniran E, et al. COVID-19 vaccine hesitancy and health literacy in US Southern states. Am J Manag Care. 2023;29(6):300-306. doi:10.37765/ajmc.2023.89371
2. Mungmunpuntipantip R, Wiwanitkit V. COVID-19 vaccination hesitancy. Recenti Prog Med. 2021;112(9):596. doi:10.1701/3658.36425
3. Xiao J, Cheung JK, Wu P, Ni MY, Cowling BJ, Liao Q. Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: serial cross-sectional surveys. Lancet Reg Health West Pac. 2022;23:100441. doi:10.1016/j.lanwpc.2022.100441
4. Marendic M, Aranza D, Aranza I, Vrdoljak D, Podrug M, Milic M. Determinants of COVID vaccination willingness among health and non-health studies students: a cross-sectional study. Vaccines (Basel). 2023;11(5):981. doi:10.3390/vaccines11050981
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More
Managed Care Reflections: A Q&A With Hoangmai H. Pham, MD, MPH
April 1st 2025To mark the 30th anniversary of The American Journal of Managed Care® (AJMC®), each issue in 2025 will include a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The April issue features a conversation with Hoangmai H. Pham, MD, MPH, a member of AJMC’s editorial board and the president and CEO of the Institute for Exceptional Care (IEC).
Read More
5 Things Every Parent Should Know About Childhood Vaccines
March 27th 2025In the wake of the 2025 measles outbreak and lingering vaccine hesitancy, here are 5 things to know about the safety, efficacy, myths, and more related to childhood vaccinations.
Read More
Challenges With Judging and Interpreting a Drug’s Launch Price
March 24th 2025This commentary explains why comparing a launch price with a value-based price from a cost-effectiveness analysis requires further examination.
Read More
Texas Measles Outbreak Could Take a Year to Contain, Health Official Warns
March 19th 2025Public health official warns the expanding measles outbreak could last a year.
Read More
Value-Based Care Is Key to Bringing Cardiology Breakthroughs to Those Who Will Benefit Most
March 13th 2025On December 10, 2024, cardiologists, researchers, and value-based care experts gathered in Dallas, Texas, to discuss best practices for implementing advances in cardiology care with a value-based mindset, spanning the care continuum from prevention to treatment.
Read More
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More
Managed Care Reflections: A Q&A With Hoangmai H. Pham, MD, MPH
April 1st 2025To mark the 30th anniversary of The American Journal of Managed Care® (AJMC®), each issue in 2025 will include a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The April issue features a conversation with Hoangmai H. Pham, MD, MPH, a member of AJMC’s editorial board and the president and CEO of the Institute for Exceptional Care (IEC).
Read More
5 Things Every Parent Should Know About Childhood Vaccines
March 27th 2025In the wake of the 2025 measles outbreak and lingering vaccine hesitancy, here are 5 things to know about the safety, efficacy, myths, and more related to childhood vaccinations.
Read More
Challenges With Judging and Interpreting a Drug’s Launch Price
March 24th 2025This commentary explains why comparing a launch price with a value-based price from a cost-effectiveness analysis requires further examination.
Read More
Texas Measles Outbreak Could Take a Year to Contain, Health Official Warns
March 19th 2025Public health official warns the expanding measles outbreak could last a year.
Read More
Value-Based Care Is Key to Bringing Cardiology Breakthroughs to Those Who Will Benefit Most
March 13th 2025On December 10, 2024, cardiologists, researchers, and value-based care experts gathered in Dallas, Texas, to discuss best practices for implementing advances in cardiology care with a value-based mindset, spanning the care continuum from prevention to treatment.
Read More